Home / Markets / Industries / Health Care
Wednesday, November 04, 2009
Novartis To Buy 85% Of Chinese Vaccines Producer
By Robert Daniel
MarketWatch Pulse
TEL AVIV -- Novartis AG, the Basel health-care giant, said on Wednesday that it definitively agreed to acquire 85% of the closely held Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co. for about $125 million cash. The Chinese company produces vaccines targeting a number of viral and bacterial diseases, Novartis said. In 2008, Zhejiang Tianyuan doubled its net sales from the 2006 level, to $25 million. The deal is subject to conditions including regulatory clearance in China. On Tuesday, Novartis had said that it planned to invest $1 billion over five years for research and development in China.
Copyright © 2009 MarketWatch, Inc.
Fox Business Video
-
-
The Crisis With 20/20 Hindsight
-
Nov 21, 2009
FOXBusiness.com LIVE
-
-
-
Jerry Rice Talks Career
-
Nov 21, 2009
NFL Receiver on career on the gridiron
-
-
-
John O'Hurley as Venture Capitalist
-
Nov 21, 2009
Comedian on life as venture capitalist
-
-
-
Excess Spending in Congress
-
Nov 21, 2009
Saving $100 Million
-
-
-
Cavuto Business Report 11-20-09
-
Nov 21, 2009
Business Report: Cavuto
-
